{"entity":{"type":"insider","cik":"0001553338","url":"/insider/0001553338","json_url":"/insider/0001553338.json","name":"Waddill William D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":21,"first":"2019-01-11","last":"2026-06-25","span_basis":"filed_date"},"name_variants":[{"name":"Waddill William D.","source":"filing","n_filings":21,"first_seen":"2019-01-11","last_seen":"2026-06-25"}],"transactions":[{"id":5796040,"accession":"0001104659-26-077761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-077761","line_url":"/filing/0001104659-26-077761#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":117.94,"price_display":"117.94","price_state":"stated","total_value":1061460.0,"total_display":"1,061,460.00","total_whole":"1,061,460","shares_owned_after":7825.0,"shares_owned_after_display":"7,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-25","scope":"insider"},{"id":5796015,"accession":"0001104659-26-073049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-073049","line_url":"/filing/0001104659-26-073049#line-3","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":107.68,"price_display":"107.68","price_state":"stated","total_value":969120.0,"total_display":"969,120.00","total_whole":"969,120","shares_owned_after":7825.0,"shares_owned_after_display":"7,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-11","scope":"insider"},{"id":6015005,"accession":"0001104659-26-069047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-069047","line_url":"/filing/0001104659-26-069047#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":99.64,"price_display":"99.64","price_state":"stated","total_value":896760.0,"total_display":"896,760.00","total_whole":"896,760","shares_owned_after":7825.0,"shares_owned_after_display":"7,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-01","scope":"insider"},{"id":5892552,"accession":"0001104659-26-011575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-011575","line_url":"/filing/0001104659-26-011575#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":83.68,"price_display":"83.68","price_state":"stated","total_value":1673600.0,"total_display":"1,673,600.00","total_whole":"1,673,600","shares_owned_after":7825.0,"shares_owned_after_display":"7,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-06","scope":"insider"},{"id":4568239,"accession":"0001553338-25-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001553338-25-000005","line_url":"/filing/0001553338-25-000005","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8367.0,"shares_display":"8,367","price_per_share":67.65125732042549,"price_display":"67.65","price_state":"stated","total_value":566038.07,"total_display":"566,038.07","total_whole":"566,038","shares_owned_after":57063.0,"shares_owned_after_display":"57,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-23","scope":"insider","n_lines":3},{"id":4851352,"accession":"0001104659-25-099252","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-099252","line_url":"/filing/0001104659-25-099252","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":81.62333333333333,"price_display":"81.62","price_state":"stated","total_value":979480.0,"total_display":"979,480.00","total_whole":"979,480","shares_owned_after":5130.0,"shares_owned_after_display":"5,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-10","filed_date":"2025-10-14","scope":"insider","n_lines":2},{"id":4956034,"accession":"0001104659-25-093046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-093046","line_url":"/filing/0001104659-25-093046#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":64.25,"price_display":"64.25","price_state":"stated","total_value":257000.0,"total_display":"257,000.00","total_whole":"257,000","shares_owned_after":5130.0,"shares_owned_after_display":"5,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-24","scope":"insider"},{"id":4249731,"accession":"0001104659-25-085795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-085795","line_url":"/filing/0001104659-25-085795#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":59.25,"price_display":"59.25","price_state":"stated","total_value":237000.0,"total_display":"237,000.00","total_whole":"237,000","shares_owned_after":9130.0,"shares_owned_after_display":"9,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-29","scope":"insider"},{"id":4064345,"accession":"0001104659-25-025535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-025535","line_url":"/filing/0001104659-25-025535#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":54.25,"price_display":"54.25","price_state":"stated","total_value":217000.0,"total_display":"217,000.00","total_whole":"217,000","shares_owned_after":13130.0,"shares_owned_after_display":"13,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":2491489,"accession":"0001628280-24-051925","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-051925","line_url":"/filing/0001628280-24-051925#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3747.0,"shares_display":"3,747","price_per_share":22.04,"price_display":"22.04","price_state":"stated","total_value":82583.88,"total_display":"82,583.88","total_whole":"82,584","shares_owned_after":40378.0,"shares_owned_after_display":"40,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-18","scope":"insider"},{"id":2491484,"accession":"0001628280-24-051925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-051925","line_url":"/filing/0001628280-24-051925#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3748.0,"shares_display":"3,748","price_per_share":21.9,"price_display":"21.90","price_state":"stated","total_value":82081.2,"total_display":"82,081.20","total_whole":"82,081","shares_owned_after":44125.0,"shares_owned_after_display":"44,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":2754123,"accession":"0001104659-24-099420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-099420","line_url":"/filing/0001104659-24-099420#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":360000.0,"total_display":"360,000.00","total_whole":"360,000","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2907640,"accession":"0001104659-24-083039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-083039","line_url":"/filing/0001104659-24-083039#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":320000.0,"total_display":"320,000.00","total_whole":"320,000","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-26","scope":"insider"},{"id":2247015,"accession":"0001104659-24-070420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-070420","line_url":"/filing/0001104659-24-070420#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":280000.0,"total_display":"280,000.00","total_whole":"280,000","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-11","scope":"insider"},{"id":2599430,"accession":"0001104659-24-030157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-030157","line_url":"/filing/0001104659-24-030157#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12975.0,"shares_display":"12,975","price_per_share":31.34,"price_display":"31.34","price_state":"stated","total_value":406636.5,"total_display":"406,636.50","total_whole":"406,637","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-01","scope":"insider"},{"id":2048257,"accession":"0001628280-24-001424","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-001424","line_url":"/filing/0001628280-24-001424","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3934.0,"shares_display":"3,934","price_per_share":38.06775292323335,"price_display":"38.07","price_state":"stated","total_value":149758.54,"total_display":"149,758.54","total_whole":"149,759","shares_owned_after":49170.0,"shares_owned_after_display":"49,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-16","scope":"insider","n_lines":2},{"id":8018366,"accession":"0001209191-23-003073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003073","line_url":"/filing/0001209191-23-003073#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":96000.0,"total_display":"96,000.00","total_whole":"96,000","shares_owned_after":28950.0,"shares_owned_after_display":"28,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6541105,"accession":"0001209191-22-001331","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-001331","line_url":"/filing/0001209191-22-001331","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":64.7209511111111,"price_display":"64.72","price_state":"stated","total_value":291244.28,"total_display":"291,244.28","total_whole":"291,244","shares_owned_after":26022.0,"shares_owned_after_display":"26,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider","n_lines":3},{"id":4923481,"accession":"0001209191-21-001481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-001481","line_url":"/filing/0001209191-21-001481#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":76.08,"price_display":"76.08","price_state":"stated","total_value":285300.0,"total_display":"285,300.00","total_whole":"285,300","shares_owned_after":30250.0,"shares_owned_after_display":"30,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":2120560,"accession":"0001209191-20-063035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-063035","line_url":"/filing/0001209191-20-063035","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":71.26,"price_display":"71.26","price_state":"stated","total_value":213780.0,"total_display":"213,780.00","total_whole":"213,780","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-11","scope":"insider","n_lines":2},{"id":2286294,"accession":"0001209191-20-028975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-028975","line_url":"/filing/0001209191-20-028975#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":36.54,"price_display":"36.54","price_state":"stated","total_value":950040.0,"total_display":"950,040.00","total_whole":"950,040","shares_owned_after":28000.0,"shares_owned_after_display":"28,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider"},{"id":8150967,"accession":"0001209191-19-003464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-003464","line_url":"/filing/0001209191-19-003464#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001553338","owner_name":"Waddill William D.","owner_display_name":"Waddill William D.","owner_url":"/insider/0001553338","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":14.77,"price_display":"14.77","price_state":"stated","total_value":125545.0,"total_display":"125,545.00","total_whole":"125,545","shares_owned_after":46500.0,"shares_owned_after_display":"46,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-11","filed_date":"2019-01-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Director","n_filings":12,"first_seen":"2024-03-01","last_seen":"2026-06-25"},{"type":"issuer","type_label":"ISSUER","cik":"0000879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","url":"/issuer/0000879407","role":"Director","n_filings":9,"first_seen":"2019-01-11","last_seen":"2025-12-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001553338","retrieved_at":"2026-08-25T01:24:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}